Atossa Therapeutics Inc (ATOS) Company Profile & Statistics

Atossa Therapeutics Inc
ATOS
(Nasdaq - US)
Closed
1.21
+0.02 (+1.68%)
in:usd•As of: Nov 22, 2024 15:59 UTC -5
After Market:1.26+0.05 (+4.13%)
Open
1.20
High
1.23
Low
1.18

About Atossa Therapeutics Inc

CEO

Steven C. Quay

Headquarters

107 spring street

seattle, wa 98104, united states

Auditor

Ernst & Young LLP

Employees

Share Holders

Website

www.atossagenetics.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA.

Atossa Therapeutics Inc Statistics

Valuation Measures

Market Capitalization ²	152.22M
Enterprise Value	77.34M
Enterprise Value/EBITDA (ttm)	-2.63
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	2.18
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-35.74%
Return on Invested Capital (ttm)	-32.73%
Return on Assets (ttm)	-33.51%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-29.46M
Net Income Avi to Common (ttm)	-26.91M
Diluted EPS (ttm)	-0.22

Share Statistics

Beta (5Y Monthly)	1.23
52-Week Change	63.51%
S&P500 52-Week Change	31.00%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	125.80M
Dividend Yield	0.00%
Float ⁴	116.24M
% Held by Insiders	7.60%
% Held by Institutions	12.74%

Balance Sheet

Total Cash (mrq)	74.88M
Total Cash Per Share (mrq)	0.60
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	13.30%
Quick Ratio (mrq)	13.30%
Book Value Per Share (mrq)	0.59

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.11
Free Cash Flow (ytd)	-14.00M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Atossa Therapeutics Inc

Trade With A Regulated Broker